Patents by Inventor Kota Ishizawa

Kota Ishizawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240245636
    Abstract: Provided is a composition for increasing muscle mass in a mammal, the composition including citric acid, a salt of citric acid, a hydrate thereof, or a mixture thereof.
    Type: Application
    Filed: May 10, 2022
    Publication date: July 25, 2024
    Applicants: TOHOKU UNIVERSITY, NIPPON CHEMIPHAR CO., LTD.
    Inventors: Michiaki ABE, Tetsuya AKAISHI, Kota ISHIZAWA, Toshiki NAKAI, Kazuhiko KAWAGUCHI, Satomi YAMASAKI, Koichiro NISHIOKA, Tetsuya SAKURAI
  • Patent number: 7838494
    Abstract: The present invention provides an agent comprising HGF for inducing differentiation of bone marrow cells into alveolar cells. The present invention also provides an HGF-containing agent for alveolar formation in pulmonary emphysema and the like in which alveoli are destroyed.
    Type: Grant
    Filed: March 7, 2005
    Date of Patent: November 23, 2010
    Assignees: Tohoku Technoarch Co., Ltd., Kringle Pharma Inc.
    Inventors: Hiroshi Kubo, Kota Ishizawa, Hidetada Sasaki, Toshikazu Nakamura
  • Publication number: 20070197433
    Abstract: The present invention provides an agent comprising HGF for inducing differentiation of bone marrow cells into alveolar cells. The present invention also provides an HGF-containing agent for alveolar formation in pulmonary emphysema and the like in which alveoli are destroyed.
    Type: Application
    Filed: March 7, 2005
    Publication date: August 23, 2007
    Inventors: Hiroshi Kubo, Kota Ishizawa, Hidetada Sasaki, Toshikazu Nakamura
  • Publication number: 20070142279
    Abstract: The present invention provides an agent for promoting induction of differentiation of bone marrow cells into endothelial progenitor cells capable of being differentiated into endothelial cells, comprising hepatocyte growth factor as an active ingredient, and such agent is useful in the field of medical therapy or regenerative medicine.
    Type: Application
    Filed: March 7, 2005
    Publication date: June 21, 2007
    Inventors: Hiroshi Kubo, Kota Ishizawa, Hidetada Sasaki, Toshikazu Nakamura